Nusano
  • Company
    • Leadership
    • Mission & Values
    • West Valley City
    • Contact Us
  • Technology
  • Life Sciences
    • Medical Isotopes
    • Request Quote
    • R&D Collaboration
    • Advisory Board
    • About Nuclear Med
  • Industrial
  • Clean Energy
  • Batteries
  • News
    • Press Releases
    • Video
    • Podcast
  • Careers
    • Current Openings
    • Life in Utah
Select Page
Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes

Nusano Announces Series C Financing of Over $115M to Commercialize Radioisotopes

by Scott Larrivee | Oct 1, 2024 | News

Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif. – Oct. 1, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C...

Recent Posts

  • Talk Radioisotopes: Dr. Luke Nordquist, Founder & CEO of XCancer
  • Nusano Names Rachel Culbertson VP of Supply Chain
  • Clarity signs high-volume commercial-scale copper-64 Supply Agreement with Nusano
  • Talk Radioisotopes: Matt Furlow, Associate Principal & Head of the ZS Radiopharmaceutical Center of Excellence
  • Talk Radioisotopes: Prof. Suzanne Lapi, University of Alabama at Birmingham

Recent Comments

No comments to show.
Nusano
Supplying the fight against cancer.
  • Follow
  • Follow
  • Follow
Company
about us
Leadership
Contact us
technology

The Nusano Platform
R&D Collaboration

Resources
News
Careers
Suppliers
© 2025 Nusano | Web design
Privacy Policy – Terms of Service